ABSTRACT Steering a system towards a desired target in a very short amount of time is a challenging task from a computational standpoint. Indeed, the intrinsically iterative nature of optimal control problems requires multiple simulations of the state of the physical system to be controlled. Moreover, the control action needs to be updated whenever the
Matteo Tomasetto +2 more
wiley +1 more source
Delandistrogene Moxeparvovec gene therapy for Duchenne muscular dystrophy: the way forward in South Asian countries. [PDF]
Madaan P +3 more
europepmc +1 more source
We propose a context‐dependent model where the Duchenne muscular dystrophy (DMD) gene acts as a tumour suppressor in aggressive tumours and as an oncogene in less aggressive ones. We propose this model as a unified framework to explain the opposing survival associations with DMD expression and to guide experimental exploration of the dual role of DMD ...
Lee Machado +4 more
wiley +1 more source
Transcytotic transportation of size-controlled nanocarriers into dystrophic skeletal muscle leads to therapeutic outcome in mice. [PDF]
Liu X +16 more
europepmc +1 more source
Proteomics of Duchenne Muscular Dystrophy Patient iPSC-Derived Skeletal Muscle Cells Reveal Differential Expression of Cytoskeletal and Extracellular Matrix Proteins. [PDF]
Gallert SM +10 more
europepmc +1 more source
Multiparametric cardiac magnetic resonance evaluation of myocardial involvement in Duchenne muscular dystrophy: A case report. [PDF]
Takamure H +8 more
europepmc +1 more source
Humanin improves bone health in a glucocorticoid-treated mouse model of Duchenne muscular dystrophy. [PDF]
Cedervall T +7 more
europepmc +1 more source
Developmental Medicine &Child Neurology, Volume 68, Issue 2, Page 295-296, February 2026.
Brian Snyder
wiley +1 more source
Caregiver-reported Patient Experiences with Duchenne Muscular Dystrophy: Qualitative In-trial Interviews 1 Year After Delandistrogene Moxeparvovec in the Pivotal EMBARK Trial. [PDF]
Audhya I +10 more
europepmc +1 more source

